Efavirenz and CYP2B6 polymorphism: Implications for drug toxicity and resistance
Tools
Nolan, D., Phillips, E. and Mallal, S. (2006) Efavirenz and CYP2B6 polymorphism: Implications for drug toxicity and resistance. Clinical Infectious Diseases, 42 (3). pp. 408-410.
Link to Published Version: http://dx.doi.org/10.1086/499369
*Subscription may be required
*Subscription may be required
Abstract
No abstract available
Item Type: | Journal Article |
---|---|
Murdoch Affiliation(s): | Centre for Clinical Immunology and Biomedical Statistics |
Publisher: | Oxford University Press |
Copyright: | 2005 The Infectious Diseases Society of America |
URI: | http://researchrepository.murdoch.edu.au/id/eprint/12694 |
![]() |
Item Control Page |
Downloads
Downloads per month over past year